CAI DRUG ABUSE CURRICULUM FOR NURSES

计算机化教育系统(CES)将进行开发、评估和营销 护理专业计算机辅助教学的课程设置 酒精和其他药物滥用的识别和干预(Aoda) 有问题。该课程将面向年内的多面手护士 各种实践环境，包括：急性护理、家庭护理、社区 健康、医生办公室、长期护理和药物滥用中心。 课程将包括来自广泛护理领域的客户。 专科，包括：内科/外科、急诊、孕产妇/儿童、 重症监护、老年病、心理健康和药物滥用。设计 将使课程可供个别护士使用，而不受 经历或教育。目标人群将从学生 护士，到所有执业环境中的多面手护士，到初级护士 在药物滥用环境中进行实践。第一阶段：工作人员进行了 文献检索和教育需求评估。从结果来看， 教学规范和课程大纲是 发展起来的。制定了评估计划。第二阶段：工作人员和 顾问将编写一份作者指南，举办一次作者研讨会， 最终确定课程，开发20个计算机辅助教学程序。计算机辅助教学程序 将接受形成性和终结性评估，包括十字 验证团队、Beta测试、离职面谈和准实验。 第三阶段：CES将把课程商业化，将其推广到 护理学校、医院、家庭医疗机构、Aoda治疗 中心和个人。

Computerized Educational Systems (CES) will develop, evaluate, and market a curriculum of computer assisted instruction (CAI) in nursing identification of and intervention in alcohol and other drug abuse (AODA) problems. The curriculum will be designed for generalist nurses in various practice settings, including: acute care, home care, community health, physicians' offices, long term care, and substance abuse centers. The curriculum will include clients from a broad range of nursing specialties, including: medical/surgical, emergency, maternal/child, critical care, geriatrics, mental health, and substance abuse. The design will enable the curriculum to be used by individual nurses regardless of experiences or education. The target population will range from student nurses, to generalist nurses in all practice settings, to nurses beginning practice in the substance abuse setting. Phase I: The staff conducted a literature search and educational needs assessment. From the results, instructional specifications and an outline for the curriculum were developed. An evaluation plan was established. Phase II: The staff and consultants will develop an Author's Guide, conduct an Author's workshop, finalize the curriculum and develop twenty CAI programs. CAI programs will undergo formative and summative evaluation including a cross validation team, beta testing, exit interviews and quasi-experiments. Phase III: CES will commercialize the curriculum by marketing it to nursing schools, hospitals, home healthcare agencies, AODA treatment centers, and individuals.